Evidence map›Paper›PMID 36962187›Full record

ArticlePLOS global public health2022

Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya.

Justin D Vrana, Nuttada Panpradist, Nikki Higa, Daisy Ko, Parker Ruth, Ruth Kanthula, James J Lai, Yaoyu Yang, Samar R Sakr, Bhavna Chohan and 5 more

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Justin D VranaDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-0862-0824
Nuttada PanpradistDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-2733-4110
Nikki HigaCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-3236-8929
Daisy KoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Parker RuthDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-1030-4916
Ruth KanthulaGlobal Health of Women, Adolescents, and Children (Global WACh), School of Public Health, University of Washington, Seattle, Washington, United States of America.
James J LaiDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Yaoyu YangDepartment of Electrical and Computer Engineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-5745-3970
Samar R SakrCoptic Hope Center for Infectious Diseases, Nairobi, Kenya.
Bhavna ChohanCenter for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-2125-6799
Michael H ChungDepartment of Medicine, Emory University, Atlanta, Georgia, United States of America.
Lisa M FrenkelCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-9566-8959
Barry R LutzDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-4298-4901
Eric KlavinsDepartment of Electrical and Computer Engineering, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-3805-5117
Ingrid A BeckCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-7438-3209
University of Washington · USInfectious Disease Research Institute · USEmory University · US

Funding

ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
V-OLA: point-of-care HIV viral load monitoring and drug resistance testingR01AI145486 · NIAID · UNIVERSITY OF WASHINGTON · PI Barry Ryan Lutz · 2019 to 2026
$5.6M
A rapid point-of-treatment diagnostic assay for HIV-resistance to 1st-line ARTR01AI110375 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2014 to 2018
$2.3M
NIAID NIH HHS R01 AI110375NIAID NIH HHS R01 AI145486NICHD NIH HHS T32 HD007233
6 · The paper itself

Abstract

Usability is an overlooked aspect of implementing lab-based assays, particularly novel assays in low-resource-settings. Esoteric instructions can lead to irreproducible test results and patient harm. To address these issues, we developed a software application based on "Aquarium", a laboratory-operating system run on a computer tablet that provides step-by-step digital interactive instructions, protocol management, and sample tracking. Aquarium was paired with a near point-of-care HIV drug resistance test, "OLA-Simple", that detects mutations associated with virologic failure. In this observational study we evaluated the performance of Aquarium in guiding untrained users through the multi-step laboratory protocol with little supervision. To evaluate the training by Aquarium software we conducted a feasibility study in a laboratory at Coptic Hope Center in Nairobi, Kenya. Twelve volunteers who were unfamiliar with the kit performed the test on blinded samples (2 blood specimens; 5 codons/sample). Steps guided by Aquarium included: CD4+ T-Cell separation, PCR, ligation, detection, and interpretation of test results. Participants filled out a short survey regarding their demographics and experience with the software and kit. None of the laboratory technicians had prior experience performing CD4+ separation and 7/12 had no experience performing laboratory-based molecular assays. 12/12 isolated CD4+ T cells from whole blood with yields comparable to isolations performed by trained personnel. The OLA-Simple workflow was completed by all, with genotyping results interpreted correctly by unaided-eye in 108/120 (90%) and by software in 116/120 (97%) of codons analyzed. In the surveys, participants favorably assessed the use of software guidance. The Aquarium digital instructions enabled first-time users in Kenya to complete the OLA-simple kit workflow with minimal training. Aquarium could increase the accessibility of laboratory assays in low-resource-settings and potentially standardize implementation of clinical laboratory tests.

Identifiers

PMID36962187
PMCPMC10021139
OpenAlexW4221090050

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.